PharmaLegacy Laboratories completes acquisition of BTS Research to strengthen preclinical services and expand operations
PharmaLegacy Laboratories completes acquisition of BTS Research to strengthen preclinical services and expand operations
09/16/24, 6:07 PM
Location
shanghai
san diegoIndustry
health care
biotechnology
PharmaLegacy Laboratories, a provider of in vitro and in vivo preclinical drug development services, has strategically acquired BTS Research, a San Diego-based CRO. This acquisition strengthens and expands PharmaLegacy’s global research capabilities and service offerings, allowing them to better serve clients across North America and advance their position as an industry-leading preclinical CRO.
Company Info
Location
Shanghai, Shanghai, China
Company info
PharmaLegacy Laboratories is a reputable provider of in vitro and in vivo preclinical drug development services, offering a wide range of preclinical pharmacology and research services to life science organizations. With a focus on efficiency and cost-effectiveness, PharmaLegacy has a proven track record of contributing to over 400 IND applications and providing validated in vitro and in vivo services across a variety of diseases.
Unlock Strategic Intelligence with Fundz
This is just a small preview. Unlock the full dataset of company insights, strategic events, and leadership shifts — all in one platform.
Trusted by sales, BD, and investment teams at Oracle, HubSpot, Affinity, and more.
Related people
JH
H